Group items tagged

Activating the immune system for therapeutic benefit in cancer has emerged as one of the most promising developments in immunology and oncology. In the past few decades, scientists have been trying to manipulate the human immune system to attack cancer cells. It's called immune therapy (or immunotherapy) and it works by harnessing the body's own natural killing cells to kill tumours. Cancer Immunotherapy has become a key part of treatment for many different types of the cancer.

Advances in cancer treatments, such as immunotherapies and precision medicines, have been associated with a corresponding rise in the cost of new and innovative medicines.

Launch of new products is expected to propel growth of the metabolomics market. For instance, in January 2021, JUNO Metabolomics launched the JUNO Viral Surveillance Platform based on its proprietary AI-Based Informatics System. Similarly, in June 2019, Bruker Corp. presented mass spectrometry and Nuclear Magnetic Resonance systems and other solutions for molecular phenomics and clinical metabolomics research at Metabolomics 2019. Moreover, increasing prevalence of chronic disorders is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Integration of Artificial Intelligence (AI) with metabolomics is expected to offer lucrative growth opportunities for players in the metabolomics market. For instance, in July 2020, ReviveMed, an AI-driven drug discovery platform, collaborated with Bristol Myers Squibb for an AI-driven metabolomics study that will leverage ReviveMed's AI platform to better understand mechanisms of response and resistance to immunotherapies in patients with cancer. Moreover, increasing demand for metabolomics is also expected to aid in growth of the market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/integration-of-ai-with-metabolomics-and.html

Overview: Many infectious diseases were historically confined to specific geographical regions. However, some now pose global threats due to ease of travel, globalization of trade and commerce and global warming. Government Agencies, non-Profit Organizations, Philanthropic groups and others are also funding vaccination programs for regions where infectious diseases are endemic and to deal with new outbreaks.. Such developments are stimulating research in and the development of improved vaccines, their manufacture and control. Supply Chain complexities and stability issues need to be addressed to cope with transport of vaccines to and their use in climatically hostile regions. Programs to address such challenges need to be implemented, being resourced by appropriately trained and qualified staff from a number of disciplines. Development programs for immuno oncology products also require staffing by similarly skilled professionals. Workers currently engaged in Discovery, Development and Manufacture of conventional medications , or those seeking career-change opportunities can develop an understanding of the concepts, constraints and opportunities associated with Vaccine products by attendance at the Webinar. Engineering professionals involved in facility construction, or repurposing can also benefit as can Regulatory Affairs Professionals or staff at medicines Evaluation Agencies. The subject matter is particularly suited to professionals who are expert in the various disciplines associated with conventional medications ("so-called "small molecules") who wish to expand and develop their skills by involvement in vaccine-related programs including immuno-oncology. Areas Covered in the Session: History of and development of vaccine concepts. undamentals of vaccination Vaccine Types Administration of Vaccines Future Concepts Immuno-Oncology Vaccine Manufacture Who Will Benefit: Regulatory Affair Managers Project Management Personnel QA Managers Scientists Technol

Many people suffer from allergies. In fact, there are millions of people who suffer from allergic reactions to a variety of substances and foods on a daily basis. For instance, , according to the study, "A cross-sectional study of the prevalence of food allergies among children younger than ages 14 years in a Beijing urban region", published in the journal Allergy & Asthma Proceedings, in January 2019, the total prevalence of probable food allergies in children aged less than 14 years of age in the Beijing urban area was 3.2%. Unfortunately, not everyone who suffers from allergies is aware of their condition or the treatments available to them. For this reason, it is important to seek proper allergy diagnostic and treatment as soon as possible in order to prevent the conditions that can lead to further complications if left untreated. To accurately assess whether or not you have a food allergy, your physician will likely: * Ask you a series of questions designed to determine your sensitivities * Perform a full physical exam * Have you maintained a detailed diary of previous symptoms and potential triggers * Have blood tests performed * Have skin tests performed * You might even be required to take a blood test for confirmation Once you know you do have allergies, your medical professional will then be able to correctly diagnose them. If your symptoms are consistent with food allergies, doctors will most likely recommend an avoidance diet in order to prevent further food allergies or other reactions. They may also prescribe daily pills to control your symptoms or provide an antihistamine to help reduce your histamine production. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/02/high-prevalence-of-food-allergies-among.html

Looking for reliable Allergy and Immunology billing services? Instapay Healthcare Services guarantees efficient coding, seamless claim submissions, and optimized revenue